© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 1.47% of KTRA shares are held by financial institutions. CONCOURSE FINANCIAL GROUP SECURITIES, INC. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Kintara Therapeutics, Inc. is owned by the company. JANE STREET GROUP, LLC owns 18.26K shares valued at $2.00K, which translates its holding of 0.02% of the stake in the company.
Among the KTRA insiders holding of 0.12% of the stake in company, LIATOS JOHN, SVP, Business Development, holds the largest shares of 196.75K. MURPHY KEITH, director, is the second largest KTRA insider with ownership of 181.01K shares. BACHA JEFFREY, CEO, stands third with possession of 61.25K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KTRA shares is 17, representing 1.47% of the company's common stock.
TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in KTRA by -13.84% restricting it's holding to 29.09 thousand shares of worth nearly $3.00K. HIGHMARK WEALTH MANAGEMENT LLC also lessened -100% of the KTRA shares from its portfolio, reducing its holding to 0 shares of worth -. TUCKER ASSET MANAGEMENT LLC also shunned KTRA shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, JANE STREET GROUP, LLC increased its stake in KTRA by 100% in the last quarter. The institutional holder raised its holding to 18.26 thousand shares having worth more than $2.00K. MARINER, LLC also added 100% more shares of KTRA to its portfolio, raising its holding to 17.94 thousand shares of worth $2.00K. MORGAN STANLEY also increased its KTRA shares holding by 219.65% which brought its holding to 1.46 thousand shares worth -.
The insider with the most stakes in KTRA is Liatos John , SVP, Business Development at the company. Additionally, KTRA stock is highly held by director Murphy Keith and CEO BACHA JEFFREY among others.
Company executives, directors, and other insiders own 0.12% percent of Kintara Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which KTRA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include GARNER WILLIAM J.
There have been 0 transaction(s) during the past 6-months in which Kintara Therapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 0 Kintara Therapeutics, Inc. shares are held by insiders, which represents about 0.12% of KTRA stock.
KTRA SVP, Business Development, Liatos John holds the largest portfolio of the company's shares. KTRA shares owned by Liatos total nearly 196.75 thousand.
CONCOURSE FINANCIAL GROUP SECURITIES, INC. is the largest institutional owner in KTRA which holds 0 shares worth - or 0% of the total KTRA shares outstanding followed by JANE STREET GROUP, LLC with ownership of 18.26 thousand shares representing 0.02% of the KTRA ownership. MARINER, LLC is the third largest stakeholder with 17.94 thousand shares or 0.02% of the ownership worth more than $2.00K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KTRA is concerned, it is a stock which is not optionable.
Number of KTRA shares short is 5.43M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 55.66M shares of KTRA are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KTRA has 1.59M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KTRA is 1.14.